Report cover image

Antibody-drug Conjugates: Technology Growth Opportunities

Publisher Frost & Sullivan
Published Dec 21, 2022
Length 68 Pages
SKU # MC17563501

Description

Antibody-drug Conjugates: Technology Growth Opportunities

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further developing this technology, with several companies developing solutions for one or more ADC components. The development of technologies is ongoing and will only increase as applications of ADCs increasingly expand into non-oncologic indications.

This study covers several new technologies for the three ADC components (antibody, linker, and payload) and highlights drugs in clinical trials that display potential. It provides an overview of key technology platforms, patents, analytical techniques, and manufacturing developments, covering the various technological advancements that may see adoption in ADC development. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. A detailed account of the funding landscape has also been provided. The study also analyzes the growth drivers and restraints influencing the market and identifies the key growth opportunities emerging from the changes in this space for stakeholders and market players to leverage.

Table of Contents

68 Pages
    • Why Is It Increasingly Difficult to Grow?
    • The Strategic Imperative 8
    • The Impact of the Top 3 Strategic Imperatives on the Antibody-drug Conjugate (ADC) Industry
    • Growth Opportunities Fuel the Growth Pipeline Engine
    • Research Methodology
    • Research Context and Scope
    • Segmentation
    • Growth Drivers
    • Growth Restraints
    • Introduction to ADCs
    • Clinical Potential of ADCs
    • ADCs: FDA Approvals
    • ADC Industry Trends
    • Incremental Innovations in ADCs
    • ADC Challenges and Novel Solutions
    • Characteristics of ADC Linkers
    • Types of Conventional ADC Linkers
    • Platforms for ADC Linkers
    • ADC Linker Developments
    • Platforms to Improve ADC Conjugation
    • Characteristics of a Suitable Antibody for ADCs
    • Platforms for ADC Antibodies
    • Antibody Developments for ADC
    • Characteristics of a Suitable Cytotoxic Payload for an ADC
    • Platforms for Cytotoxic Payload for an ADC
    • Payload Developments for ADCs
    • Novel Platforms for ADC Delivery
    • Impact on CDMOs
    • ADC: Analysis Technologies, Challenges, and New Developments
    • ADC: Clinical Pipeline
    • M&As
    • Partnerships and Collaborations for ADCs
    • Technology Licensing Deals for ADC Development
    • Funding Analysis
    • Growth Opportunity 1: Non-oncological Indications
    • Growth Opportunity 2: Manufacturing and Supply Chain
    • Growth Opportunity 3: Advancements in Linker Chemistry and Antibodies
    • Your Next Steps
    • Why Frost, Why Now?

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us